An opinion piece on the case of Darcy Doherty, who is dying of melanoma and wishes to ‘roll the dice’ one last time with an experimental drug that the maker, Bristol-Myers Squibb, has refused given their concerns about patient safety (see original story here). Quote:
Canada needs a public debate about the need for compassionate access legislation, so that carefully selected patients with no other alternative can access drugs, under a doctor’s supervision. While it is important to maintain rigorous scientific methods when running clinical trials, in cases of catastrophic illness, the system should be more nimble in allowing terminally ill people to obtain prompt access.
Kudos for Darcy and his family for raising this issue and getting the necessary public attention.